CLUSTER filed Aug 18, 2026 at 16:17 ET
Relay Therapeutics' CEO and CFO sold a combined $1.33M in open-market sales over a 4-day window, representing ~0.03% of the $4.5B market cap. While the dollar amount is trivial relative to company size, the cluster involves both the CEO and CFO selling simultaneously, which is notable for a biotech with a $4.5B market cap and 95% analyst bullishness. The sales are not part of a 10b5-1 plan pattern and occur without any disclosed negative catalyst, suggesting potential insider caution ahead of upcoming pipeline data or earnings.